Brief: Avalo Therapeutics Appoints Michael Heffernan As Chairman Of The Board
26/03/2025 11:47
March 26 (Reuters) - Avalo Therapeutics Inc AVTX.O: AVALO THERAPEUTICS APPOINTS MICHAEL HEFFERNAN AS CHAIRMAN OF THE BOARD AVALO THERAPEUTICS - GARRY NEIL TO REMAIN AS CEO AND BOARD MEMBER Source text: ID:nGNX8mG9R Further company coverage: AVTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biohaven
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
Brief: Biohaven - FDA Accepts Biohaven NDA Resubmission For Vyglxia (Troriluzole) In SCA
Biohaven jumps as FDA takes second look at brain disorder drug
Brief: Biohaven Enters Strategic Licensing Agreement With Ono Pharma
Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean